Decoy Therapeutics Inc. (DCOY) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.5x

Market Cap

$1.76M

MomentumView details →

1D Return

−6.60%

YTD Return

−64.18%

RSI (14)

29.2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.5x

Market Cap

$1.76M

RSI (14)

29.2

MomentumView details →

1D Return

−6.60%

YTD Return

−64.18%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−334.41%

ROA (TTM)

−160.53%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

+48.31%

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

+70.10%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−$4.46

EPS Surprise

−54.86%

Beats (12Q)

7/12

Next Q EPS Est

−$3.12

Avg Surprise (4Q)

29.47%

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

1.83x

Quick Ratio

1.83x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−14.45M

Op. CF (TTM)

−8.32M

Next earningsNov 13, 2026 →

Latest newsMore news →

Decoy Therapeutics entered into a securities purchase agreement for a private placement financing expected to provide approximately $3.5 million in gross proceeds.70d ago

Similar companies

Protagenic Therapeutics, Inc.PTIX Avenue Therapeutics, Inc.ATXI Clearmind Medicine Inc.CMND Silexion Therapeutics Ltd.SLXN Liminatus Pharma, Inc. WarrantsLIMNW Virax Biolabs Group LimitedVRAX Find similar companies →

Latest newsMore news →

Decoy Therapeutics entered into a securities purchase agreement for a private placement financing expected to provide approximately $3.5 million in gross proceeds.70d ago